Khan M T, Wang K K, Villalobo A, Roufogalis B D
Department of Pharmacy, University of Sydney, New South Wales, Australia.
J Biol Chem. 1994 Apr 1;269(13):10016-21.
A previously undescribed high molecular mass protein (HMP) from human erythrocyte membranes was solubilized by Triton X-100 and purified on a calmodulin-agarose column in the presence of Ca2+. It was shown to have a native molecular mass of 522-560 kDa, comprised of a single subunit of a molecular mass of 28 kDa (p28). The protein is associated with the lipid bilayer rather than with the cytoskeletal component of the membrane. The purified HMP showed peptidase-hydrolyzing activity toward substrates containing hydrophobic amino acids at the P1 position of the P2-P1 cleavage site. The activity was inhibited by serine proteinase inhibitors (leupeptin, phenylmethansulfonyl fluoride) and chymotrypsin inhibitors in particular (chymostatin, N-tosyl-L-phenylalanine chloromethyl ketone). The enzyme exhibited maximal activity at slightly alkaline pH (7.5-8.5) and at 37 degrees C and was stimulated over a narrow range of SDS concentrations (maximal at 0.05%). HMP was found to cross-react in Western blots with an antibody raised against the rabbit multicatalytic proteinase. The single subunit of HMP therefore contains both the catalytic activity and a sequence necessary for its association into a multimeric complex. The properties of the human erythrocyte membrane HMP described indicate that it is a novel peptidase related to the ubiquitous multicatalytic proteinase.
一种先前未被描述的来自人红细胞膜的高分子量蛋白质(HMP)通过Triton X-100溶解,并在Ca2+存在下于钙调蛋白-琼脂糖柱上进行纯化。结果显示其天然分子量为522 - 560 kDa,由一个分子量为28 kDa的单一亚基(p28)组成。该蛋白质与脂质双层相关,而非与膜的细胞骨架成分相关。纯化后的HMP对在P2 - P1切割位点的P1位置含有疏水氨基酸的底物表现出肽酶水解活性。该活性受到丝氨酸蛋白酶抑制剂(亮抑酶肽、苯甲基磺酰氟)尤其是胰凝乳蛋白酶抑制剂(抑糜酶素、N - 甲苯磺酰 - L - 苯丙氨酸氯甲基酮)的抑制。该酶在略碱性pH(7.5 - 8.5)和37℃时表现出最大活性,并在狭窄的SDS浓度范围内受到刺激(在0.05%时最大)。发现HMP在蛋白质免疫印迹中与针对兔多催化蛋白酶产生的抗体发生交叉反应。因此,HMP的单一亚基既包含催化活性,又包含其缔合成多聚体复合物所需的序列。所描述的人红细胞膜HMP的特性表明它是一种与普遍存在的多催化蛋白酶相关的新型肽酶。